Mwanzo1099 • HKG
add
Sinopharm Group Co Ltd
Bei iliyotangulia
$ 20.55
Bei za siku
$ 19.80 - $ 20.85
Bei za mwaka
$ 16.02 - $ 23.65
Thamani ya kampuni katika soko
62.57B HKD
Wastani wa hisa zilizouzwa
9.37M
Uwiano wa bei na mapato
6.73
Mgao wa faida
4.77%
Ubadilishanaji wa msingi
HKG
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 147.36B | -5.19% |
Matumizi ya uendeshaji wa biashara | 6.78B | 4.18% |
Mapato halisi | 1.85B | -26.34% |
Kiwango cha faida halisi | 1.26 | -22.22% |
Mapato kwa kila hisa | — | — |
EBITDA | 4.76B | -25.05% |
Asilimia ya kodi ya mapato | 22.34% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 43.33B | 26.05% |
Jumla ya mali | 429.58B | 2.85% |
Jumla ya dhima | 307.15B | 0.84% |
Jumla ya hisa | 122.43B | — |
hisa zilizosalia | 3.12B | — |
Uwiano wa bei na thamani | 0.85 | — |
Faida inayotokana na mali | 2.44% | — |
Faida inayotokana mtaji | 4.69% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.85B | -26.34% |
Pesa kutokana na shughuli | -20.50B | -678.47% |
Pesa kutokana na uwekezaji | -519.26M | -167.92% |
Pesa kutokana na ufadhili | 10.78B | 5,713.58% |
Mabadiliko halisi ya pesa taslimu | -10.24B | -512.13% |
Mtiririko huru wa pesa | 2.71B | 108.45% |
Kuhusu
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Ilianzishwa
2003
Tovuti
Wafanyakazi
113,635
